These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 12888801

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Monoaminergic mechanisms in affective disorders.
    Syvälahti E.
    Med Biol; 1987; 65(2-3):89-96. PubMed ID: 2888934
    [Abstract] [Full Text] [Related]

  • 23. Valproic acid inhibits corticotropin-releasing factor synthesis and release from the rat hypothalamus in vitro: evidence for the involvement of GABAergic neurotransmission.
    Tringali G, Aubry JM, Moscianese K, Zamori C, Vairano M, Preziosi P, Navarra P, Pozzoli G.
    J Psychiatry Neurosci; 2004 Nov; 29(6):459-66. PubMed ID: 15644987
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Sensorimotor modulation of mood and depression: an integrative review.
    Canbeyli R.
    Behav Brain Res; 2010 Mar 05; 207(2):249-64. PubMed ID: 19913058
    [Abstract] [Full Text] [Related]

  • 26. Similarities and interactions between GABAergic and glutaminergic systems.
    Car H, Wiśniewski K.
    Rocz Akad Med Bialymst; 1998 Mar 05; 43():5-26. PubMed ID: 9972040
    [Abstract] [Full Text] [Related]

  • 27. GABAergic circuits in the basal ganglia and movement disorders.
    Galvan A, Wichmann T.
    Prog Brain Res; 2007 Mar 05; 160():287-312. PubMed ID: 17499121
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. An update on regional brain volume differences associated with mood disorders.
    Campbell S, MacQueen G.
    Curr Opin Psychiatry; 2006 Jan 05; 19(1):25-33. PubMed ID: 16612175
    [Abstract] [Full Text] [Related]

  • 32. [Psychopharmacology of GABA].
    Gerardy J.
    J Pharm Belg; 1982 Jan 05; 37(6):435-41. PubMed ID: 7161703
    [Abstract] [Full Text] [Related]

  • 33. Intracellular signaling pathways pave roads to recovery for mood disorders.
    Tanis KQ, Duman RS.
    Ann Med; 2007 Jan 05; 39(7):531-44. PubMed ID: 17852035
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic strategies in migraine patients with mood and anxiety disorders: physiopathological basis.
    Casucci G, Villani V, Finocchi C.
    Neurol Sci; 2010 Jun 05; 31 Suppl 1():S99-101. PubMed ID: 20464595
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The peripheral GABAergic system as a target in endocrine disorders.
    Gladkevich A, Korf J, Hakobyan VP, Melkonyan KV.
    Auton Neurosci; 2006 Jan 30; 124(1-2):1-8. PubMed ID: 16338174
    [Abstract] [Full Text] [Related]

  • 38. Evidence for impaired cortical inhibition in patients with unipolar major depression.
    Bajbouj M, Lisanby SH, Lang UE, Danker-Hopfe H, Heuser I, Neu P.
    Biol Psychiatry; 2006 Mar 01; 59(5):395-400. PubMed ID: 16197927
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders.
    Kurt E, Guler O, Serteser M, Cansel N, Ozbulut O, Altinbaş K, Alataş G, Savaş H, Gecici O.
    Neurosci Lett; 2007 Oct 09; 426(1):49-53. PubMed ID: 17884293
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.